Paper Details

  1. Home
  2. Paper Details

[Intravenous administration of lidocaine and amiodarone in patients with acute myocardial infarction].

Author: CapucciA, MagnaniB, MantovaniB, MarestaA, MelandriG

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Amiodarone was as effective as lidocaine in treating life-threatening ventricular arrhythmias in patients with acute myocardial infarction. Amiodarone prolonged the QTc interval and slightly decreased systolic blood pressure.
Paper Details　
Original Abstract of the Article :
Lidocaine (L) in still considered the drug of choice in the treatment of life threatening ventricular arrhythmias in the setting of acute myocardial infarction (A.M.I.): this is mainly due to its proved efficacy and high therapeutic index. Since however L has well defined electrophysiologic properti...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/4018467

データ提供：米国国立医学図書館（NLM）

Acute Myocardial Infarction: A Critical Situation

In the heart of the medical world, we constantly strive to find ways to address life-threatening conditions. This study explores the use of lidocaine (L) and amiodarone (A) in treating life-threatening ventricular arrhythmias, a dangerous condition that can occur during acute myocardial infarction (AMI). It's like a caravan leader facing a sudden sandstorm, needing to act quickly and decisively to ensure the safety of their group.

Lidocaine and Amiodarone: Two Different Approaches

The study found that both L and A were effective in relieving ventricular arrhythmias during AMI. However, they work through different mechanisms, like two caravans navigating through a desert using different strategies. L is a class 1B antiarrhythmic agent, while A is a class 4 agent. The study highlighted the importance of understanding the unique properties of each drug when choosing the most appropriate treatment for a specific patient.

Navigating the Terrain of AMI

This study underscores the need for careful assessment and individualized treatment approaches for patients with AMI. Just as a caravan leader adjusts their course based on the terrain and weather conditions, healthcare professionals must carefully consider the specific needs of each patient when choosing between L and A.

Dr. Camel's Conclusion

Acute myocardial infarction, like a sudden desert storm, requires a rapid and decisive response. This study provides valuable insights into the use of L and A in managing ventricular arrhythmias. By understanding the distinct properties of each drug, healthcare professionals can navigate this challenging terrain and provide the most effective treatment for patients experiencing AMI.

Date :
  1. Date Completed 1985-09-25
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

4018467

DOI: Digital Object Identifier

4018467

SNS
PICO Info
in preparation
Languages

Italian

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.